Цитирование
Thyroid hormone receptor-β agonist simedeutirom (HSK31679) for Chinese patients with metabolic dysfunction-associated steatohepatitis: a 52-week, multicentre, randomised, double-blind, placebo-controlled, phase 2b trial. // The Lancet Gastroenterology & Hepatology. – URL: https://www.sciencedirect.com/science/article/pii/S2468125326002438?dgcid=rss_sd_all
Thyroid hormone receptor-β agonist simedeutirom (HSK31679) for Chinese patients with metabolic dysfunction-associated steatohepatitis: a 52-week, multicentre, randomised, double-blind, placebo-controlled, phase 2b trial. The Lancet Gastroenterology & Hepatology. https://www.sciencedirect.com/science/article/pii/S2468125326002438?dgcid=rss_sd_all
“Thyroid hormone receptor-β agonist simedeutirom (HSK31679) for Chinese patients with metabolic dysfunction-associated steatohepatitis: a 52-week, multicentre, randomised, double-blind, placebo-controlled, phase 2b trial.” The Lancet Gastroenterology & Hepatology.
@article{article68746,
title = {Thyroid hormone receptor-β agonist simedeutirom (HSK31679) for Chinese patients with metabolic dysfunction-associated steatohepatitis: a 52-week, multicentre, randomised, double-blind, placebo-controlled, phase 2b trial},
journal = {The Lancet Gastroenterology \& Hepatology},
url = {https://www.sciencedirect.com/science/article/pii/S2468125326002438?dgcid=rss_sd_all}
}